Cargando…
Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers
Cancer associated fibroblasts (CAF) and the extracellular matrix (ECM) produced by them have been recognized as key players in cancer biology and emerged as important targets for cancer treatment and drug discovery. Apart from their presence in stroma rich tumors, such as biliary, pancreatic and sub...
Autores principales: | Kaps, Leonard, Schuppan, Detlef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563527/ https://www.ncbi.nlm.nih.gov/pubmed/32899119 http://dx.doi.org/10.3390/cells9092027 |
Ejemplares similares
-
Fluorescence Correlation Spectroscopy Monitors the
Fate of Degradable Nanocarriers in the Blood Stream
por: Schmitt, Sascha, et al.
Publicado: (2022) -
Novel Opportunities for Cathepsin S Inhibitors in Cancer Immunotherapy by Nanocarrier-Mediated Delivery
por: Fuchs, Natalie, et al.
Publicado: (2020) -
In Vivo siRNA Delivery to Immunosuppressive Liver Macrophages by α-Mannosyl-Functionalized Cationic Nanohydrogel Particles
por: Kaps, Leonard, et al.
Publicado: (2020) -
Fibroblast Activation Protein Activates Macrophages and Promotes Parenchymal Liver Inflammation and Fibrosis
por: Yang, Ai-Ting, et al.
Publicado: (2022) -
Advances of cancer-associated fibroblasts in liver cancer
por: Peng, Hao, et al.
Publicado: (2022)